- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06368583
The Patient AS EDUcator in Anesthesia: Exploring the Patients' and Providers' Experience During Neuraxial Labour Analgesia (PAS-EDU-NLA)
The Patient AS EDUcator in Anesthesia: Exploring the Patients' and Providers' Experience During Neuraxial Labour Analgesia. A Prospective Patient-centered Multidisciplinary Quality Improvement Study. (PAS-EDU-NLA)
During the process of labour and delivery, patients may experience a wide range of events in a short time frame. This study focuses on exploring these experiences and aims to incorporate the improvements from these experiences so that in future, the expectations of patients delivering can be met as much as possible. Since every patient and encounter is unique, they might have a variety of experiences, be it during the labour epidural placement or during the delivery of the baby. Our study aims to explore the patients' perspective and learn about their preferences, concerns and suggestions regarding their experience and to then use this information to enhance the quality of future anesthesia care during labour and delivery.
Patients who underwent labour and delivery and received labour epidural for pain management will be approached the day following the delivery, while their recollection of their experience is still fresh, and given the opportunity to participate in the study which will involve the completion of a questionnaire as well as an interview lasting approximately 20-25 minutes. In addition to interviewing the patients, the study will also involve several interviews of the obstetricians, anesthesiologists, and nurses with the goals of seeing how the patients' experiences compare to the providers' perspective of the care they are delivering. Following the gathering of this information and identification of potential improvements in current practice, a follow up study will be performed aiming to implement changes and improve the quality of anesthesia care during labour and delivery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sabine Nabecker, MD
- Phone Number: 5270 416-586-4800
- Email: sabine.nabecker@sinaihealth.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X5
- Mount Sinai Hospital
-
Sub-Investigator:
- Kristi Downey, MSc
-
Contact:
- Sabine Nabecker, MD
- Phone Number: 5270 416-586-4800
- Email: sabine.nabecker@sinaihealth.ca
-
Sub-Investigator:
- Ron George, MD
-
Sub-Investigator:
- Afsheen Nasir, MD
-
Sub-Investigator:
- Sunti Barahi, MD
-
Sub-Investigator:
- Ratesh Bassi, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- aged 18 years and older
- ASA Physical Classification Score II or III
- Patients having vaginal delivery and LEA
- Singleton or Multiple pregnancy
Exclusion Criteria:
- under 18 years of age
- unwilling to provide written informed consent, or unable to follow the questions due to their mental state or language barriers.
- Patients who delivered via Cesarean section
- TOP/ IUFDs
- requiring instrumental deliveries- for example forceps or vacuum
- requiring to go to the OR postpartum for PPH or other reasons
- BMI at the time of delivery that falls in the super-morbidly obese category (BMI >55kg/m2)
- Preterm delivery (under 37 weeks of gestation)
- Patients who had inadvertent Dural Puncture during epidural placement
- Patients who had contraindicated or failed epidural anesthesia and required IV PCA for or during their delivery will also be excluded
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Vaginal delivery with neuraxial analgesia
Patients who have a vaginal delivery with neuraxial analgesia.
|
Patients will be interviewed by the research team to learn about their experience of vaginal delivery with neuraxial analgesia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient interview
Time Frame: Following scheduled c-section delivery, and prior to hospital discharge (at approximately 48 hours postpartum).
|
Patients will be interviewed in person by a member of the research team and asked open ended questions. Interviews will be recorded, transcribed and coded for themes. Responses are not reported on any scale. The interview will take approximately 30 minutes to complete. |
Following scheduled c-section delivery, and prior to hospital discharge (at approximately 48 hours postpartum).
|
Patient questionnaire
Time Frame: Following scheduled c-section delivery, and prior to hospital discharge (at approximately 48 hours postpartum).
|
Patients will be asked to rate their experience of having a vaginal delivery with neuraxial analgesia, in terms of satisfaction and their experience with any discomfort. Some questions are yes/no, some are on a scale from 1-10, where 1 = not at all and 10 = totally agree, and some are open-ended. The questionnaire will take approximately 10 minutes to complete. |
Following scheduled c-section delivery, and prior to hospital discharge (at approximately 48 hours postpartum).
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sabine Nabecker, Mount Sinai Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 24-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Well-Being, Psychological
-
University of JyvaskylaAcademy of FinlandCompleted
-
Cardiff UniversityNot yet recruiting
-
University of RochesterCenters for Disease Control and PreventionNot yet recruitingWell-Being, PsychologicalUnited States
-
FitnessGenes Ltd.Not yet recruiting
-
Samuel Lunenfeld Research Institute, Mount Sinai...Not yet recruitingWell-Being, PsychologicalCanada
-
Cultech LtdCwm Taff Morgannwg University Health Board; Welsh Ambuance services TrustNot yet recruitingWell-Being, Psychological
-
Samuel Lunenfeld Research Institute, Mount Sinai...RecruitingWell-Being, PsychologicalCanada
-
University of Wisconsin, MadisonNot yet recruiting
-
Hong Kong Metropolitan UniversityNot yet recruiting
-
Larena SASNot yet recruitingWell-Being, PsychologicalFrance
Clinical Trials on Interview
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
Ohio UniversityNew York Blood CenterCompleted
-
University of New MexicoCompletedPregnancy TerminationUnited States
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
Centro Hospitalar Lisboa NorteUniversity of Lisbon; Faculdade de Psicologia e de Ciências de Educação da...Unknown
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceCompletedCancer | Elderly | Ethnographic Interview | Social Representation of Being Aged | Reasons of Non-participation in Clinical Trials | Qualitative MethodFrance
-
Dongzhimen Hospital, BeijingUnknown
-
University of Eastern FinlandCompleted
-
University Hospital, GrenobleRegional Council of Auvergne-Rhône-AlpesRecruitingTraumatic Brain InjuryFrance
-
Northwestern UniversityRegeneron PharmaceuticalsCompletedPsoriasis | Atopic Dermatitis | IchthyosisUnited States